Form D Explorer

Inspect source fieldsReport a record issue

Form D — Grace Therapeutics, Inc.

0001123292-26-001084 · filed Aug 11, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$9,999,998
Reported amount sold
$9,999,998
Minimum investment
$1
Investors
9
Sales commission
$560,000
Finders' fees
$0

Issuer

Name
Grace Therapeutics, Inc.
CIK
1444192
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
103 CARNEGIE CENTER
PRINCETON, New Jersey 08540
Phone
609-322-1602

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗